Global Digital PCR (d-PCR) Market: Focus on Product-Type, Application, End User, Region, and Competitive Landscape - Analysis and Forecast, 2020-2025
Hard copy option is available on any of the options above at an additional charge of $500. Please email us at [email protected] with your request.
Market Report Coverage - Digital PCR (d-PCR)
Market Segmentation
Thermo Fisher Scientific, Bio-Rad Laboratories, Inc.., Optolane Technologies, Inc., Qiagen NV, Sysmex Corporation, SAGA Diagnostics AB, Stem Genomics, Fluidigm Corporation, Combinati, Merck KGaA, JN Medsys, Stilla Technologies, Dropworks, Inc. Naveris, Inc. Genetron Holdings Limited
Key Questions Answered in this Report:
BIS Research healthcare experts have found digital PCR (d-PCR) market to be one of the most rapidly evolving markets and the global market for digital PCR (d-PCR) is predicted to grow at a CAGR of 17.57% over the forecast period of 2020-2025. The market is driven by certain factors, which include the rising incidence of infectious disease, such as recent pandemic COVID-19, inciting the development of high-throughput diagnostics, increasing adoption of personalized medicine for the screening and diagnostics of genetic disorders, and significant external funding for executing R&D exercises.
The market is favored by the development of digital PCR-based solutions for early diagnosis and rare mutation detection with absolute quantification of target sample. The gradual increase in the prevalence of infectious disease due to pandemic COVID-19 globally has furthered the digital PCR (d-PCR) market.
Furthermore, several diagnostic companies are focusing on the development of digital PCR diagnostics with higher sensitivity and low turn-around time to benefit the patients, enabling patient-based outcomes.
Within the research report, the market is segmented on the basis of product type, application, end users, and region. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.
Competitive Landscape
The exponential rise in the application of precision medicine on the global level has created a buzz among companies to invest in the development of rapid diagnostics providing information on genetic mutation and patients good candidate for adjuvant chemotherapy or hormonal therapy. Due to the diverse product portfolio and intense market penetration, Bio-Rad Laboratories, Inc. has been a pioneer in this field and been a significant competitor in this market.
Several other companies, such as Qiagen NV, Sysmex Corporation., and Stilla Technlogies, among others, have launched technologically advanced digital PCR platforms, such as QIAcuity Digital PCR System, OncoBEAM digital PCR, and Naica System.
On the basis of region, North America holds the largest share of digital PCR (d-PCR) market due to improved healthcare infrastructure, rise in per capita income, and availability of state-of-the-art research laboratories and institutions in the region. Apart from this, Asia-Pacific region is anticipated to grow at the fastest CAGR of 18.11% during the forecast period.
Market Report Coverage - Digital PCR (d-PCR)
Market Segmentation
- Product Type – Assays and Reagents, Platforms, Accessories, and Instruments
- Application- Clinical, Environmental Monitoring, Food and Agriculture and Others
- End User – Hospital and Clinics, Academic and Research Institutions, Diagnostic Centers, and Other End Users
- North America – U.S., Canada
- Europe – Germany, France, Italy, U.K., Spain, and Rest-of-Europe
- Asia-Pacific – China, Japan, India, Singapore, Australia, and Rest-of-Asia-Pacific (RoAPAC)
- Latin America – Brazil, Mexico, and Rest-of-the-Latin America
- Rest-of-the-World
- Rising Incidence of Infectious Disease, such as recent pandemic COVID-19, Inciting the Development of High-throughput Diagnostics
- Increasing Adoption of Personalized Medicine for the Screening and Diagnostics of Genetic Disorders
- Significant External Funding for Executive R&D Exercises
- Shortage of Skilled Professionals and Trained Lab-Technicians
- High Cost of Platforms Associated with Digital-PCR
- Massive Scope for Adoption of Genomic-Based Medicine in Emerging Nations
- Technological Advancements in the development of Digital PCR-based Solutions
- Increased Use of Digital PCR-Based Solutions for the Development of Therapeutics Drugs and Comprehensive Treatment Plan
Thermo Fisher Scientific, Bio-Rad Laboratories, Inc.., Optolane Technologies, Inc., Qiagen NV, Sysmex Corporation, SAGA Diagnostics AB, Stem Genomics, Fluidigm Corporation, Combinati, Merck KGaA, JN Medsys, Stilla Technologies, Dropworks, Inc. Naveris, Inc. Genetron Holdings Limited
Key Questions Answered in this Report:
- What are the major market drivers, challenges, and opportunities in the global digital PCR market?
- What is the potential impact of biotechnological advancement in diagnostic industry among the end users, such as researchers, physicians, and laboratory technicians?
- What is the current market demand along with future expected demand of global digital PCR market?
- How has digital PCR helped genomic tests to become a prominent tool for diagnostics in various clinical applications?
- What are the key development strategies which are implemented by the major players in order to sustain in the competitive market?
- How each segment of the market is expected to grow during the forecast period from 2020 to 2025 based on:
- Product Type
- Clinical Area
- End user
- Region: Region includes North America, Europe, Asia-Pacific, Rest-of-the-World (ROW)?
- Who are the leading players with significant offerings to the global digital PCR (d-PCR) market? What is the expected market dominance for each of these leading players?
- Which companies are anticipated to be highly disruptive in the future, and why?
BIS Research healthcare experts have found digital PCR (d-PCR) market to be one of the most rapidly evolving markets and the global market for digital PCR (d-PCR) is predicted to grow at a CAGR of 17.57% over the forecast period of 2020-2025. The market is driven by certain factors, which include the rising incidence of infectious disease, such as recent pandemic COVID-19, inciting the development of high-throughput diagnostics, increasing adoption of personalized medicine for the screening and diagnostics of genetic disorders, and significant external funding for executing R&D exercises.
The market is favored by the development of digital PCR-based solutions for early diagnosis and rare mutation detection with absolute quantification of target sample. The gradual increase in the prevalence of infectious disease due to pandemic COVID-19 globally has furthered the digital PCR (d-PCR) market.
Furthermore, several diagnostic companies are focusing on the development of digital PCR diagnostics with higher sensitivity and low turn-around time to benefit the patients, enabling patient-based outcomes.
Within the research report, the market is segmented on the basis of product type, application, end users, and region. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.
Competitive Landscape
The exponential rise in the application of precision medicine on the global level has created a buzz among companies to invest in the development of rapid diagnostics providing information on genetic mutation and patients good candidate for adjuvant chemotherapy or hormonal therapy. Due to the diverse product portfolio and intense market penetration, Bio-Rad Laboratories, Inc. has been a pioneer in this field and been a significant competitor in this market.
Several other companies, such as Qiagen NV, Sysmex Corporation., and Stilla Technlogies, among others, have launched technologically advanced digital PCR platforms, such as QIAcuity Digital PCR System, OncoBEAM digital PCR, and Naica System.
On the basis of region, North America holds the largest share of digital PCR (d-PCR) market due to improved healthcare infrastructure, rise in per capita income, and availability of state-of-the-art research laboratories and institutions in the region. Apart from this, Asia-Pacific region is anticipated to grow at the fastest CAGR of 18.11% during the forecast period.
EXECUTIVE SUMMARY
1 PRODUCT DEFINITION
1.1 Definition by Product
1.1.1 Platforms
1.1.2 Assays and Reagents
1.1.3 Accessories and Instruments
1.2 Inclusion and Exclusion
1.3 Scope of Work
1.4 Key Questions Answered in the Report
2 RESEARCH METHODOLOGY
2.1 Primary Data Sources
2.2 Secondary Data Sources
2.3 Market Estimation Model
2.4 Criteria for Company Profiling
3 MARKET OVERVIEW
3.1 Digital PCR: A Next-Generation PCR Technology
3.2 Digital PCR(d-PCR) vs. Quantitative PCR (q-PCR)
3.3 COVID-19 Impact on Digital PCR (d-PCR)
3.4 Digital PCR Clinical Trials
4 GLOBAL DIGITAL PCR (D-PCR) MARKET DYNAMICS
4.1 Overview
4.2 Impact Analysis
4.3 Market Drivers
4.3.1 Rising Incidence of Infectious Disease, such as recent pandemic COVID-19, Inciting the Development of High-throughput Diagnostics
4.3.2 Increasing Adoption of Personalized Medicine for Screening and Diagnostics of Genetic Disorders such as Rare Diseases and Cancer
4.3.3 Significant External Funding for Executing Research & Development Exercises
4.4 Market Restraints
4.4.1 Shortage of Skilled Professionals and Trained Lab-Technicians
4.4.2 High Cost of Platforms Associated with Digital-PCR
4.5 Market Opportunities
4.5.1 Massive Scope for Adoption of Genomic-Based Medicine in Emerging Nations
4.5.2 Technological Advancements in the Development of Digital-PCR Based Solutions
4.5.3 Increased Use of Digital-PCR-Based Solutions for the Development of Therapeutics Drugs and Comprehensive Treatment Plan
5 COMPETITIVE LANDSCAPE
5.1 Key Strategies and Developments
5.1.1 Product Approvals
5.1.2 Product Launches and Upgradations
5.1.3 Synergistic Activities
5.1.4 Funding and Expansion
5.1.5 Mergers and Acquisitions
5.2 Patent Analysis
5.3 Market Share Analysis (by Company) 2019
5.4 Growth Share Analysis (Opportunity Mapping)
5.4.1 By Company
5.5 Regulatory Framework
5.5.1 Legal Requirements and Framework in the U.S.
5.5.2 Legal Requirements and Framework in Europe
5.5.3 Legal Requirements and Framework in Asia-Pacific
5.5.3.1 China
5.5.3.2 Japan
6 GLOBAL DIGITAL PCR (D-PCR) MARKET, BY PRODUCT $MILLION, 2019-2025
6.1 Introduction
6.2 Assays and Reagents
6.3 Platforms
6.3.1 Droplet-Based Digital PCR (d-PCR)
6.3.2 Chip-Based Digital PCR (d-PCR)
6.4 Accessories and Instruments
7 GLOBAL DIGITAL PCR (D-PCR) MARKET (BY APPLICATION) $MILLION, 2019-2025
7.1 Clinical
7.1.1 Oncology
7.1.2 Non-Oncology
7.1.2.1 Infectious Disease
7.1.2.2 Non-Invasive Prenatal Testing (NIPT)
7.1.2.3 Forensics
7.2 Environmental Monitoring
7.3 Food and Agriculture
7.4 Other Applications
8 DIGITAL PCR (D-PCR) MARKET (BY END USER), 2019-2025
8.1 Overview
8.2 Hospitals and Clinics
8.3 Academic and Research Institutions
8.4 Diagnostic Centers
8.5 Other End Users
9 GLOBAL DIGITAL PCR (D-PCR) MARKET (BY REGION), 2019-2025
9.1 Overview
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest-of-Europe
9.4 Asia-Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 Singapore
9.4.6 Rest-of-APAC
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest-of-Latin America
9.6 Rest-of-the-World
10 COMPANY PROFILES
10.1 Overview
10.2 Bio-Rad Laboratories, Inc.
10.2.1 Company Overview
10.2.2 Role of Bio-Rad Laboratories, Inc. in Global Digital PCR Market
10.2.3 Financials
10.2.4 Key Insights About Financial Health of the Company
10.2.5 SWOT Analysis
10.3 Combinati
10.3.1 Company Overview
10.3.2 Role of Combinati in Global Digital PCR Market
10.3.3 SWOT Analysis
10.4 Dropworks, Inc.
10.4.1 Company Overview
10.4.2 Role of Dropworks, Inc. in Global Digital PCR Market
10.5 Fluidigm Corporation
10.5.1 Company Overview
10.5.2 Role of Fluidigm Corporation in Global Digital PCR Market
10.5.3 Financials
10.5.4 Key Insights About Financial Health of the Company
10.5.5 SWOT Analysis
10.6 Genetron Holdings Limited
10.6.1 Company Overview
10.6.2 Role of Genetron Holdings Limited in Global Digital PCR Market
10.6.3 Financials
10.6.4 Key Insights About Financial Health of the Company
10.6.5 SWOT Analysis
10.7 JN Medsys
10.7.1 Company Overview
10.7.2 Role of JN Medsys in Global Digital PCR Market
10.7.3 SWOT Analysis
10.8 Merck KGaA
10.8.1 Company Overview
10.8.2 Role of Merck KGaA in Global Digital PCR Market
10.8.3 Financials
10.8.4 Key Insights About Financial Health of the Company
10.8.5 SWOT Analysis
10.9 Naveris, Inc.
10.9.1 Company Overview
10.9.2 Role of Naveris, Inc. in Global Digital PCR Market
10.9.3 SWOT Analysis
10.1 OPTOLANE Technologies Inc.
10.10.1 Company Overview
10.10.2 Role of OPTOLANE Technologies in Global Digital PCR Market
10.10.3 SWOT Analysis
10.11 QIAGEN N.V.
10.11.1 Company Overview
10.11.2 Role of QIAGEN N.V. in Global Digital PCR Market
10.11.3 Financials
10.11.4 Key Insights About Financial Health of the Company
10.11.5 SWOT Analysis
10.13 Saga Diagnostics AB
10.13.1 Company Overview
10.13.2 Role of Saga Diagnostics AB in Global Digital PCR Market
10.13.3 SWOT Analysis
10.14 Stem Genomics
10.14.1 Company Overview
10.14.2 Role of Stem Genomics in Global Digital PCR Market
10.14.3 SWOT Analysis
10.15 Sysmex Corporation
10.15.1 Company Overview
10.15.2 Role of Sysmex Corporation in Global Digital PCR Market
10.15.3 Financials
10.15.4 Key Insights About Financial Health of the Company
10.15.5 SWOT Analysis
10.16 Stilla Technologies Inc.
10.16.1 Company Overview
10.16.2 Role of Stilla Technologies Inc. in Global Digital PCR Market
10.16.3 SWOT Analysis
10.17 Thermo Fisher Scientific Inc.
10.17.1 Company Overview
10.17.2 Role of Thermo Fisher Scientific Inc. in Global Digital PCR Market
10.17.3 Financials
10.17.4 Key Insights About Financial Health of the Company
10.17.5 SWOT Analysis
1 PRODUCT DEFINITION
1.1 Definition by Product
1.1.1 Platforms
1.1.2 Assays and Reagents
1.1.3 Accessories and Instruments
1.2 Inclusion and Exclusion
1.3 Scope of Work
1.4 Key Questions Answered in the Report
2 RESEARCH METHODOLOGY
2.1 Primary Data Sources
2.2 Secondary Data Sources
2.3 Market Estimation Model
2.4 Criteria for Company Profiling
3 MARKET OVERVIEW
3.1 Digital PCR: A Next-Generation PCR Technology
3.2 Digital PCR(d-PCR) vs. Quantitative PCR (q-PCR)
3.3 COVID-19 Impact on Digital PCR (d-PCR)
3.4 Digital PCR Clinical Trials
4 GLOBAL DIGITAL PCR (D-PCR) MARKET DYNAMICS
4.1 Overview
4.2 Impact Analysis
4.3 Market Drivers
4.3.1 Rising Incidence of Infectious Disease, such as recent pandemic COVID-19, Inciting the Development of High-throughput Diagnostics
4.3.2 Increasing Adoption of Personalized Medicine for Screening and Diagnostics of Genetic Disorders such as Rare Diseases and Cancer
4.3.3 Significant External Funding for Executing Research & Development Exercises
4.4 Market Restraints
4.4.1 Shortage of Skilled Professionals and Trained Lab-Technicians
4.4.2 High Cost of Platforms Associated with Digital-PCR
4.5 Market Opportunities
4.5.1 Massive Scope for Adoption of Genomic-Based Medicine in Emerging Nations
4.5.2 Technological Advancements in the Development of Digital-PCR Based Solutions
4.5.3 Increased Use of Digital-PCR-Based Solutions for the Development of Therapeutics Drugs and Comprehensive Treatment Plan
5 COMPETITIVE LANDSCAPE
5.1 Key Strategies and Developments
5.1.1 Product Approvals
5.1.2 Product Launches and Upgradations
5.1.3 Synergistic Activities
5.1.4 Funding and Expansion
5.1.5 Mergers and Acquisitions
5.2 Patent Analysis
5.3 Market Share Analysis (by Company) 2019
5.4 Growth Share Analysis (Opportunity Mapping)
5.4.1 By Company
5.5 Regulatory Framework
5.5.1 Legal Requirements and Framework in the U.S.
5.5.2 Legal Requirements and Framework in Europe
5.5.3 Legal Requirements and Framework in Asia-Pacific
5.5.3.1 China
5.5.3.2 Japan
6 GLOBAL DIGITAL PCR (D-PCR) MARKET, BY PRODUCT $MILLION, 2019-2025
6.1 Introduction
6.2 Assays and Reagents
6.3 Platforms
6.3.1 Droplet-Based Digital PCR (d-PCR)
6.3.2 Chip-Based Digital PCR (d-PCR)
6.4 Accessories and Instruments
7 GLOBAL DIGITAL PCR (D-PCR) MARKET (BY APPLICATION) $MILLION, 2019-2025
7.1 Clinical
7.1.1 Oncology
7.1.2 Non-Oncology
7.1.2.1 Infectious Disease
7.1.2.2 Non-Invasive Prenatal Testing (NIPT)
7.1.2.3 Forensics
7.2 Environmental Monitoring
7.3 Food and Agriculture
7.4 Other Applications
8 DIGITAL PCR (D-PCR) MARKET (BY END USER), 2019-2025
8.1 Overview
8.2 Hospitals and Clinics
8.3 Academic and Research Institutions
8.4 Diagnostic Centers
8.5 Other End Users
9 GLOBAL DIGITAL PCR (D-PCR) MARKET (BY REGION), 2019-2025
9.1 Overview
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest-of-Europe
9.4 Asia-Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 Singapore
9.4.6 Rest-of-APAC
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest-of-Latin America
9.6 Rest-of-the-World
10 COMPANY PROFILES
10.1 Overview
10.2 Bio-Rad Laboratories, Inc.
10.2.1 Company Overview
10.2.2 Role of Bio-Rad Laboratories, Inc. in Global Digital PCR Market
10.2.3 Financials
10.2.4 Key Insights About Financial Health of the Company
10.2.5 SWOT Analysis
10.3 Combinati
10.3.1 Company Overview
10.3.2 Role of Combinati in Global Digital PCR Market
10.3.3 SWOT Analysis
10.4 Dropworks, Inc.
10.4.1 Company Overview
10.4.2 Role of Dropworks, Inc. in Global Digital PCR Market
10.5 Fluidigm Corporation
10.5.1 Company Overview
10.5.2 Role of Fluidigm Corporation in Global Digital PCR Market
10.5.3 Financials
10.5.4 Key Insights About Financial Health of the Company
10.5.5 SWOT Analysis
10.6 Genetron Holdings Limited
10.6.1 Company Overview
10.6.2 Role of Genetron Holdings Limited in Global Digital PCR Market
10.6.3 Financials
10.6.4 Key Insights About Financial Health of the Company
10.6.5 SWOT Analysis
10.7 JN Medsys
10.7.1 Company Overview
10.7.2 Role of JN Medsys in Global Digital PCR Market
10.7.3 SWOT Analysis
10.8 Merck KGaA
10.8.1 Company Overview
10.8.2 Role of Merck KGaA in Global Digital PCR Market
10.8.3 Financials
10.8.4 Key Insights About Financial Health of the Company
10.8.5 SWOT Analysis
10.9 Naveris, Inc.
10.9.1 Company Overview
10.9.2 Role of Naveris, Inc. in Global Digital PCR Market
10.9.3 SWOT Analysis
10.1 OPTOLANE Technologies Inc.
10.10.1 Company Overview
10.10.2 Role of OPTOLANE Technologies in Global Digital PCR Market
10.10.3 SWOT Analysis
10.11 QIAGEN N.V.
10.11.1 Company Overview
10.11.2 Role of QIAGEN N.V. in Global Digital PCR Market
10.11.3 Financials
10.11.4 Key Insights About Financial Health of the Company
10.11.5 SWOT Analysis
10.13 Saga Diagnostics AB
10.13.1 Company Overview
10.13.2 Role of Saga Diagnostics AB in Global Digital PCR Market
10.13.3 SWOT Analysis
10.14 Stem Genomics
10.14.1 Company Overview
10.14.2 Role of Stem Genomics in Global Digital PCR Market
10.14.3 SWOT Analysis
10.15 Sysmex Corporation
10.15.1 Company Overview
10.15.2 Role of Sysmex Corporation in Global Digital PCR Market
10.15.3 Financials
10.15.4 Key Insights About Financial Health of the Company
10.15.5 SWOT Analysis
10.16 Stilla Technologies Inc.
10.16.1 Company Overview
10.16.2 Role of Stilla Technologies Inc. in Global Digital PCR Market
10.16.3 SWOT Analysis
10.17 Thermo Fisher Scientific Inc.
10.17.1 Company Overview
10.17.2 Role of Thermo Fisher Scientific Inc. in Global Digital PCR Market
10.17.3 Financials
10.17.4 Key Insights About Financial Health of the Company
10.17.5 SWOT Analysis
LIST OF TABLES
Table 3.1: Digital PCR(d-PCR) vs. Quantitative PCR (q-PCR)
Table 3.2: Digital PCR (d-PCR) Diagnostics Solutions Offered for COVID-19
Table 3.3: Digital PCR (d-PCR) Clinical Trials
Table 4.1: Likert Scale
Table 4.2: Impact Analysis of Market Drivers
Table 4.3: Impact Analysis of Market Restraints
Table 4.4: Funding Allocated for Precision Medicine to Different Agencies in U.S.
Table 4.5: Funding for the Development of Digital PCR-based Diagnostics
Table 4.6: Cost for Different Commercialized Digital PCR (d-PCR) Platforms
Table 5.1: Global Digital PCR (d-PCR) Patents 2016-2020
Table 5.2: Classification Rules of IVDs Under the IVDR
Table 5.3: Registration Criteria for IVD Medical Devices as per the CFDA
Table 6.1: Market Available Digital PCR (d-PCR) Assay and Reagents
Table 6.2: Market Available Digital PCR (d-PCR) Platforms
Table 6.3: Market Available Digital PCR (d-PCR) Accessories and Instruments
Table 3.1: Digital PCR(d-PCR) vs. Quantitative PCR (q-PCR)
Table 3.2: Digital PCR (d-PCR) Diagnostics Solutions Offered for COVID-19
Table 3.3: Digital PCR (d-PCR) Clinical Trials
Table 4.1: Likert Scale
Table 4.2: Impact Analysis of Market Drivers
Table 4.3: Impact Analysis of Market Restraints
Table 4.4: Funding Allocated for Precision Medicine to Different Agencies in U.S.
Table 4.5: Funding for the Development of Digital PCR-based Diagnostics
Table 4.6: Cost for Different Commercialized Digital PCR (d-PCR) Platforms
Table 5.1: Global Digital PCR (d-PCR) Patents 2016-2020
Table 5.2: Classification Rules of IVDs Under the IVDR
Table 5.3: Registration Criteria for IVD Medical Devices as per the CFDA
Table 6.1: Market Available Digital PCR (d-PCR) Assay and Reagents
Table 6.2: Market Available Digital PCR (d-PCR) Platforms
Table 6.3: Market Available Digital PCR (d-PCR) Accessories and Instruments
LIST OF FIGURES
Figure 1: Total Global Disease Burden (by Cause), 2017
Figure 2: Impact Analysis of Market Drivers and Market Challenges on the Global Digital PCR (d-PCR) Market
Figure 3: Global Digital PCR (d-PCR) Market (by Product Type) $Million, 2020 vs. 2025
Figure 4: Global Digital-PCR (d-PCR) Market (by Application) $Million, 2020 vs. 2025
Figure 5: Digital PCR (d-PCR) Market (by End User) $Million, 2020 vs. 2025
Figure 6: Global Digital-PCR (d-PCR) Market Snapshot
Figure 1.1: Global Digital-PCR (d-PCR) Market Segments
Figure 2.1: Primary Research Methodology
Figure 3.1: Working of Digital PCR
Figure 3.2: Evolution of Digital PCR
Figure 4.1: New Cases of Respiratory and Enteric Infections, Globally, 2012-2017
Figure 4.2: Benefits of Multiplexing Infectious Disease Rapid Diagnostic Testing
Figure 5.1: Share of Key Developments and Strategies, 2017-2020
Figure 5.2: Product Launch and Upgradation Share (by Company), 2017-2020
Figure 5.3: Synergistic Activities Share (by Company), 2017-2020
Figure 5.4: Funding and Expansion Share (by Company), 2017–2020
Figure 5.5: Market Share Analysis for the Global Digital PCR (d-PCR) Market, 2019
Figure 5.6: Growth Share Matrix for Global Digital PCR (d-PCR) Market (by company), 2019
Figure 5.7: Components Considered for Clinical Evidence as per the IVDR
Figure 5.8: Process for Medical Device Designation by The MHLW and PDMA72
Figure 6.1: Digital PCR (d-PCR) Market (by Product Type) $Million, 2019-2025
Figure 6.2: Global Digital PCR (d-PCR) Market (Assays and Reagents) $Million, 2019-2025
Figure 6.3: Digital PCR (d-PCR) Market (Platforms), 2019-2025 ($Millions)
Figure 6.4: Digital PCR (d-PCR) Market (Droplet-Based), 2019-2025 ($Millions)
Figure 6.5: Digital PCR (d-PCR) Market (Chip-Based), 2019-2025 ($Millions)
Figure 6.6: Digital PCR (d-PCR) Market (Accessories and Instruments), 2019-2025 ($ Million)
Figure 7.1: Global Digital PCR (d-PCR) Market (by Application) $Million, 2019-2025
Figure 7.2: Global Digital PCR (d-PCR) Market (by Clinical Application) $Million, 2019-2025
Figure 7.3: Digital PCR (d-PCR) Market (Oncology) $Million, 2019-2025
Figure 7.4: Digital PCR (d-PCR) Application Market (Non-Oncology) $Million, 2019-2025
Figure 7.5: Digital PCR (d-PCR) Non-Oncology Market (by Type) $Million, 2019-2025
Figure 7.6: Digital PCR (d-PCR) Market (by Infectious Disease) $Million, 2019-2025
Figure 7.7: Digital PCR (d-PCR) Market (by NIPT) $Million, 2019-2025
Figure 7.8: Digital PCR (d-PCR) Market (by Forensics) $Million, 2019-2025
Figure 7.9: Digital PCR (d-PCR) Market (Environmental Monitoring) $Million, 2019-2025
Figure 7.10: Digital PCR (d-PCR) Market (Food and Agriculture) $Million, 2019-2025
Figure 7.11: Digital PCR (d-PCR) Market (Other Application) $Million, 2019-2025
Figure 8.1: Global Digital PCR (d-PCR) Market $Million, by End User, 2019-2025
Figure 8.2: Global Digital PCR (d-PCR) Market (Hospitals and Clinics) $Million, 2019-2025
Figure 8.3: Global Digital PCR (d-PCR) Market (by Academic and Research Institutions), 2019-2025
Figure 8.4: Global Digital PCR (d-PCR) Market (Diagnostic Centers) $Million, 2019-2025
Figure 8.5: Global Digital PCR (d-PCR) Market (by Other End-User) $Million, 2019-2025
Figure 9.1: Global Digital PCR (d-PCR) Market (by Region) $Million, 2020 and 2025
Figure 9.2: Global Digital PCR (d-PCR) Market (by Region) $Million, 2019-2025
Figure 9.3: North America: Market Dynamics
Figure 9.4: North America Digital PCR (d-PCR) $Million, 2019-2025
Figure 9.5: North America Digital PCR (d-PCR) (by Country) $Million, 2019-2025
Figure 9.6: U.S. Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 9.7: Canada Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 9.8: Europe: Market Dynamics
Figure 9.9: Europe Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 9.10: Europe Digital PCR (d-PCR) Market (by Country) $Million, 2019-2025
Figure 9.11: Germany Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 9.12: U.K. Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 9.13: France Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 9.14: Italy Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 9.15: Spain Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 9.16: Rest-of-Europe Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 9.17: APAC: Market Dynamics
Figure 9.18: Asia-Pacific Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 9.19: APAC Digital PCR (d-PCR) market (by Country) $Million, 2019-2025
Figure 9.20: China Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 9.21: Japan Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 9.22: India Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 9.23: Australia Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 9.24: Singapore Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 9.25: RoAPAC Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 8.26: Latin America: Market Dynamics
Figure 9.27: Latin America Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 9.28: Latin America Digital PCR (d-PCR) Market (by Country) $Million, 2019-2025
Figure 9.29: Brazil Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 9.30: Mexico Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 9.31: Rest-of-Latin America Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 9.32: RoW Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 10.1: Total Number of Companies Profiled
Figure 10.2: Bio-Rad Laboratories, Inc.: Product Portfolio
Figure 10.3: Bio-Rad Laboratories, Inc.: Overall Financials, 2017-2019
Figure 10.4: Bio-Rad Laboratories, Inc.: Revenue (by Segment), 2017-2019
Figure 10.5: Bio-Rad Laboratories, Inc.: Revenue (by Region), 2017-2019
Figure 10.6: Bio-Rad Laboratories, Inc.: R&D Expenditure, 2017-2019
Figure 10.7: Bio-Rad Laboratories, Inc.: SWOT Analysis
Figure 10.8: Combinati: Product Portfolio
Figure 10.9: Combinati: SWOT Analysis
Figure 10.10: Dropworks, Inc.: Product Portfolio
Figure 10.11: Fluidigm Corporation: Product Portfolio
Figure 10.12: Fluidigm Corporation: Overall Financials, 2017-2019
Figure 10.13: Fluidigm Corporation: Revenue (by Business Segment), 2017-2019
Figure 10.14: Fluidigm Corporation.: Revenue (by Region), 2017-2019
Figure 10.15: Fluidigm Corporation: R&D Expenditure, 2017-2019
Figure 10.16: Fluidigm Corporation: SWOT Analysis
Figure 10.17: Genetron Holdings Limited: Product Portfolio
Figure 10.18: Genetron Holdings Limited: Overall Financials, 2017-2019
Figure 10.19: Genetron Holdings Limited: Revenue (by Business Segment), 2017-2019
Figure 10.20: Genetron Holdings Limited: R&D Expenditure (2017-2019)
Figure 10.21: Genetron Holdings Limited: SWOT Analysis
Figure 10.22: JN Medsys: Product Portfolio
Figure 10.23 JN Medsys: SWOT Analysis
Figure 10.24: Merck KGaA: Product Portfolio
Figure 10.25: Merck KGaA: Overall Financials, 2017-2019
Figure 10.26: Merck KGaA: Revenue (by Segment), 2017-2019
Figure 10.27: Merck KGaA: Revenue (by Region), 2017-2019
Figure 10.28: Merck KGaA: R&D Expenditure, 2017-2019
Figure 10.29: Merck KGaA: SWOT Analysis
Figure 10.30: Naveris, Inc.: Product Portfolio
Figure 10.31: Naveris, Inc.: SWOT Analysis
Figure 10.32: OPTOLANE Technologies Inc.: Product Portfolio
Figure 10.33: OPTOLANE Technologies Inc.: SWOT Analysis
Figure 10.34: QIAGEN N.V.: Product Offerings
Figure 10.35: QIAGEN N.V.: Overall Financials, 2017-2019
Figure 10.36: QIAGEN N.V.: Revenue (by Segment) $Million, 2017-2019
Figure 10.37: QIAGEN N.V.: Revenue (by Region), 2017-2019
Figure 10.38: QIAGEN N.V.: R&D Expenditure, 2017-2019
Figure 10.39: QIAGEN N.V.: SWOT Analysis
Figure 10.40: SAGA Diagnostics AB: Product Portfolio
Figure 10.41: SAGA Diagnostics AB: SWOT Analysis
Figure 10.42: Stem Genomics: Product Portfolio
Figure 10.43: Stem Genomics: SWOT Analysis
Figure 10.44: Sysmex Corporation: Overall Product Portfolio
Figure 10.45: Sysmex Corporation: Overall Financials, 2017-2019
Figure 10.46: Sysmex Corporation: Sales (by Segment), 2017-2019
Figure 10.47: Sysmex Corporation: Sales (by Region), 2017-2019
Figure 10.48: Sysmex Corporation: Research and Development Expenditure, 2017-2019
Figure 10.49: Sysmex Corporation: SWOT Analysis
Figure 10.50: Stilla Technologies Inc.: Product Portfolio
Figure 10.51: Stilla Technologies Inc.: SWOT Analysis
Figure 10.52: Thermo Fisher Scientific Inc.: Product Portfolio
Figure 10.53: Thermo Fisher Scientific Inc.: Overall Financials, 2017-2019
Figure 10.54: Thermo Fisher Scientific Inc.: Revenue (by Business Segment), 2017-2019
Figure 10.55: Thermo Fisher Scientific Inc.: Revenue (by Region), 2017-2019
Figure 10.56: Thermo Fisher Scientific Inc.: R&D Expenditure (2017-2019)
Figure 10.57: Thermo Fisher Scientific Inc.: SWOT Analysis
Figure 1: Total Global Disease Burden (by Cause), 2017
Figure 2: Impact Analysis of Market Drivers and Market Challenges on the Global Digital PCR (d-PCR) Market
Figure 3: Global Digital PCR (d-PCR) Market (by Product Type) $Million, 2020 vs. 2025
Figure 4: Global Digital-PCR (d-PCR) Market (by Application) $Million, 2020 vs. 2025
Figure 5: Digital PCR (d-PCR) Market (by End User) $Million, 2020 vs. 2025
Figure 6: Global Digital-PCR (d-PCR) Market Snapshot
Figure 1.1: Global Digital-PCR (d-PCR) Market Segments
Figure 2.1: Primary Research Methodology
Figure 3.1: Working of Digital PCR
Figure 3.2: Evolution of Digital PCR
Figure 4.1: New Cases of Respiratory and Enteric Infections, Globally, 2012-2017
Figure 4.2: Benefits of Multiplexing Infectious Disease Rapid Diagnostic Testing
Figure 5.1: Share of Key Developments and Strategies, 2017-2020
Figure 5.2: Product Launch and Upgradation Share (by Company), 2017-2020
Figure 5.3: Synergistic Activities Share (by Company), 2017-2020
Figure 5.4: Funding and Expansion Share (by Company), 2017–2020
Figure 5.5: Market Share Analysis for the Global Digital PCR (d-PCR) Market, 2019
Figure 5.6: Growth Share Matrix for Global Digital PCR (d-PCR) Market (by company), 2019
Figure 5.7: Components Considered for Clinical Evidence as per the IVDR
Figure 5.8: Process for Medical Device Designation by The MHLW and PDMA72
Figure 6.1: Digital PCR (d-PCR) Market (by Product Type) $Million, 2019-2025
Figure 6.2: Global Digital PCR (d-PCR) Market (Assays and Reagents) $Million, 2019-2025
Figure 6.3: Digital PCR (d-PCR) Market (Platforms), 2019-2025 ($Millions)
Figure 6.4: Digital PCR (d-PCR) Market (Droplet-Based), 2019-2025 ($Millions)
Figure 6.5: Digital PCR (d-PCR) Market (Chip-Based), 2019-2025 ($Millions)
Figure 6.6: Digital PCR (d-PCR) Market (Accessories and Instruments), 2019-2025 ($ Million)
Figure 7.1: Global Digital PCR (d-PCR) Market (by Application) $Million, 2019-2025
Figure 7.2: Global Digital PCR (d-PCR) Market (by Clinical Application) $Million, 2019-2025
Figure 7.3: Digital PCR (d-PCR) Market (Oncology) $Million, 2019-2025
Figure 7.4: Digital PCR (d-PCR) Application Market (Non-Oncology) $Million, 2019-2025
Figure 7.5: Digital PCR (d-PCR) Non-Oncology Market (by Type) $Million, 2019-2025
Figure 7.6: Digital PCR (d-PCR) Market (by Infectious Disease) $Million, 2019-2025
Figure 7.7: Digital PCR (d-PCR) Market (by NIPT) $Million, 2019-2025
Figure 7.8: Digital PCR (d-PCR) Market (by Forensics) $Million, 2019-2025
Figure 7.9: Digital PCR (d-PCR) Market (Environmental Monitoring) $Million, 2019-2025
Figure 7.10: Digital PCR (d-PCR) Market (Food and Agriculture) $Million, 2019-2025
Figure 7.11: Digital PCR (d-PCR) Market (Other Application) $Million, 2019-2025
Figure 8.1: Global Digital PCR (d-PCR) Market $Million, by End User, 2019-2025
Figure 8.2: Global Digital PCR (d-PCR) Market (Hospitals and Clinics) $Million, 2019-2025
Figure 8.3: Global Digital PCR (d-PCR) Market (by Academic and Research Institutions), 2019-2025
Figure 8.4: Global Digital PCR (d-PCR) Market (Diagnostic Centers) $Million, 2019-2025
Figure 8.5: Global Digital PCR (d-PCR) Market (by Other End-User) $Million, 2019-2025
Figure 9.1: Global Digital PCR (d-PCR) Market (by Region) $Million, 2020 and 2025
Figure 9.2: Global Digital PCR (d-PCR) Market (by Region) $Million, 2019-2025
Figure 9.3: North America: Market Dynamics
Figure 9.4: North America Digital PCR (d-PCR) $Million, 2019-2025
Figure 9.5: North America Digital PCR (d-PCR) (by Country) $Million, 2019-2025
Figure 9.6: U.S. Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 9.7: Canada Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 9.8: Europe: Market Dynamics
Figure 9.9: Europe Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 9.10: Europe Digital PCR (d-PCR) Market (by Country) $Million, 2019-2025
Figure 9.11: Germany Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 9.12: U.K. Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 9.13: France Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 9.14: Italy Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 9.15: Spain Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 9.16: Rest-of-Europe Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 9.17: APAC: Market Dynamics
Figure 9.18: Asia-Pacific Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 9.19: APAC Digital PCR (d-PCR) market (by Country) $Million, 2019-2025
Figure 9.20: China Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 9.21: Japan Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 9.22: India Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 9.23: Australia Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 9.24: Singapore Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 9.25: RoAPAC Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 8.26: Latin America: Market Dynamics
Figure 9.27: Latin America Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 9.28: Latin America Digital PCR (d-PCR) Market (by Country) $Million, 2019-2025
Figure 9.29: Brazil Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 9.30: Mexico Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 9.31: Rest-of-Latin America Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 9.32: RoW Digital PCR (d-PCR) Market $Million, 2019-2025
Figure 10.1: Total Number of Companies Profiled
Figure 10.2: Bio-Rad Laboratories, Inc.: Product Portfolio
Figure 10.3: Bio-Rad Laboratories, Inc.: Overall Financials, 2017-2019
Figure 10.4: Bio-Rad Laboratories, Inc.: Revenue (by Segment), 2017-2019
Figure 10.5: Bio-Rad Laboratories, Inc.: Revenue (by Region), 2017-2019
Figure 10.6: Bio-Rad Laboratories, Inc.: R&D Expenditure, 2017-2019
Figure 10.7: Bio-Rad Laboratories, Inc.: SWOT Analysis
Figure 10.8: Combinati: Product Portfolio
Figure 10.9: Combinati: SWOT Analysis
Figure 10.10: Dropworks, Inc.: Product Portfolio
Figure 10.11: Fluidigm Corporation: Product Portfolio
Figure 10.12: Fluidigm Corporation: Overall Financials, 2017-2019
Figure 10.13: Fluidigm Corporation: Revenue (by Business Segment), 2017-2019
Figure 10.14: Fluidigm Corporation.: Revenue (by Region), 2017-2019
Figure 10.15: Fluidigm Corporation: R&D Expenditure, 2017-2019
Figure 10.16: Fluidigm Corporation: SWOT Analysis
Figure 10.17: Genetron Holdings Limited: Product Portfolio
Figure 10.18: Genetron Holdings Limited: Overall Financials, 2017-2019
Figure 10.19: Genetron Holdings Limited: Revenue (by Business Segment), 2017-2019
Figure 10.20: Genetron Holdings Limited: R&D Expenditure (2017-2019)
Figure 10.21: Genetron Holdings Limited: SWOT Analysis
Figure 10.22: JN Medsys: Product Portfolio
Figure 10.23 JN Medsys: SWOT Analysis
Figure 10.24: Merck KGaA: Product Portfolio
Figure 10.25: Merck KGaA: Overall Financials, 2017-2019
Figure 10.26: Merck KGaA: Revenue (by Segment), 2017-2019
Figure 10.27: Merck KGaA: Revenue (by Region), 2017-2019
Figure 10.28: Merck KGaA: R&D Expenditure, 2017-2019
Figure 10.29: Merck KGaA: SWOT Analysis
Figure 10.30: Naveris, Inc.: Product Portfolio
Figure 10.31: Naveris, Inc.: SWOT Analysis
Figure 10.32: OPTOLANE Technologies Inc.: Product Portfolio
Figure 10.33: OPTOLANE Technologies Inc.: SWOT Analysis
Figure 10.34: QIAGEN N.V.: Product Offerings
Figure 10.35: QIAGEN N.V.: Overall Financials, 2017-2019
Figure 10.36: QIAGEN N.V.: Revenue (by Segment) $Million, 2017-2019
Figure 10.37: QIAGEN N.V.: Revenue (by Region), 2017-2019
Figure 10.38: QIAGEN N.V.: R&D Expenditure, 2017-2019
Figure 10.39: QIAGEN N.V.: SWOT Analysis
Figure 10.40: SAGA Diagnostics AB: Product Portfolio
Figure 10.41: SAGA Diagnostics AB: SWOT Analysis
Figure 10.42: Stem Genomics: Product Portfolio
Figure 10.43: Stem Genomics: SWOT Analysis
Figure 10.44: Sysmex Corporation: Overall Product Portfolio
Figure 10.45: Sysmex Corporation: Overall Financials, 2017-2019
Figure 10.46: Sysmex Corporation: Sales (by Segment), 2017-2019
Figure 10.47: Sysmex Corporation: Sales (by Region), 2017-2019
Figure 10.48: Sysmex Corporation: Research and Development Expenditure, 2017-2019
Figure 10.49: Sysmex Corporation: SWOT Analysis
Figure 10.50: Stilla Technologies Inc.: Product Portfolio
Figure 10.51: Stilla Technologies Inc.: SWOT Analysis
Figure 10.52: Thermo Fisher Scientific Inc.: Product Portfolio
Figure 10.53: Thermo Fisher Scientific Inc.: Overall Financials, 2017-2019
Figure 10.54: Thermo Fisher Scientific Inc.: Revenue (by Business Segment), 2017-2019
Figure 10.55: Thermo Fisher Scientific Inc.: Revenue (by Region), 2017-2019
Figure 10.56: Thermo Fisher Scientific Inc.: R&D Expenditure (2017-2019)
Figure 10.57: Thermo Fisher Scientific Inc.: SWOT Analysis
